UniSuper Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$98.2M Buy
1,152,567
+144,462
+14% +$12.9M 0.64% 35
2025
Q4
$79.7M Buy
1,008,105
+157,370
+18% +$12.3M 0.48% 39
2025
Q3
$68M Sell
850,735
-169,102
-17% -$14.4M 0.42% 46
2025
Q2
$92.7M Buy
1,019,837
+70,927
+7% +$6.48M 0.62% 26
2025
Q1
$88.9M Buy
948,910
+133,173
+16% +$11.9M 0.66% 23
2024
Q4
$74.2M Buy
815,737
+35,315
+5% +$3.37M 0.53% 35
2024
Q3
$81M Buy
780,422
+143,789
+23% +$14.7M 0.61% 30
2024
Q2
$61.8M Buy
636,633
+318,503
+100% +$29.4M 0.51% 38
2024
Q1
$28.6M Buy
318,130
+14,452
+5% +$1.22M 0.27% 80
2023
Q4
$24.2M Buy
303,678
+860
+0.3% +$64.7K 0.27% 88
2023
Q3
$21.5M Sell
302,818
-5,651
-2% -$423K 0.26% 89
2023
Q2
$23.8M Buy
+308,469
New +$23.9M 0.27% 79

Other funds holding CL

UniSuper Management's CL Position: Q1 2026 in Review

UniSuper Management increased its Colgate-Palmolive (CL) stake by 14% in Q1 2026, buying an estimated $12.9M and bringing the position to 1,152,567 shares worth $98.2M. The position accounts for 0.64% of the portfolio, ranked #35.

UniSuper Management first reported a position in CL in Q2 2023 and has held it in 12 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • UniSuper Management held 1,152,567 shares of Colgate-Palmolive worth $98.2M as of Q1 2026.
  • UniSuper Management bought 144,462 Colgate-Palmolive shares in Q1 2026, an estimated $12.9M.
  • Colgate-Palmolive made up 0.64% of UniSuper Management's portfolio in Q1 2026, its #35 holding.
  • UniSuper Management first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 12 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on UniSuper Management's 13F filing for Q1 2026, filed 11 May 2026.